New cell therapy trial offers hope for Tough-to-Treat blood cancer
NCT ID NCT07100067
Summary
This study is testing an experimental cell therapy called LCAR-F33S for people with multiple myeloma that has returned or stopped responding to standard treatments. Researchers will give the therapy to about 35 patients to check how safe it is and whether it can help control the cancer. The study will help determine the best dose for future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Boren Hospital
NOT_YET_RECRUITINGBeijing, China
Contact Email: •••••@•••••
-
Institute of Hematology & Blood Diseases Hospital
RECRUITINGTianjin, China
-
Institute of Hematology & Blood Diseases Hospital
RECRUITINGTianjin, China
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Wuhan Union Hospital
RECRUITINGWuhan, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.